KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cvs Health (CVS) Operating Leases (2019 - 2025)

Cvs Health (CVS) has disclosed Operating Leases for 7 consecutive years, with $16.7 billion as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Operating Leases rose 12.13% year-over-year to $16.7 billion, compared with a TTM value of $16.7 billion through Dec 2025, up 12.13%, and an annual FY2025 reading of $16.7 billion, up 12.13% over the prior year.
  • Operating Leases was $16.7 billion for Q4 2025 at Cvs Health, up from $14.0 billion in the prior quarter.
  • Across five years, Operating Leases topped out at $18.6 billion in Q1 2021 and bottomed at $14.0 billion in Q3 2025.
  • Average Operating Leases over 5 years is $16.5 billion, with a median of $16.6 billion recorded in 2023.
  • Peak annual rise in Operating Leases hit 12.13% in 2025, while the deepest fall reached 8.2% in 2025.
  • Year by year, Operating Leases stood at $18.2 billion in 2021, then fell by 7.58% to $16.8 billion in 2022, then fell by 4.56% to $16.0 billion in 2023, then dropped by 7.08% to $14.9 billion in 2024, then increased by 12.13% to $16.7 billion in 2025.
  • Business Quant data shows Operating Leases for CVS at $16.7 billion in Q4 2025, $14.0 billion in Q3 2025, and $14.3 billion in Q2 2025.